Macrophage-colony stimulating factor (M-CSF) enhances proteinuria and recruitment of macrophages into the glomerulus in experimental murine nephritis.
In this study, we examined the effects of macrophage-colony stimulating factor (M-CSF) on glomerular macrophages in lipopolysaccharide (LPS)-induced murine nephritis. Mice injected intraperitoneally with either M-CSF plus LPS, LPS alone, M-CSF alone or saline every day for 8 days were examined for the degree of urine albumin excretion and lymphocyte-function associated antigen-1-positive (LFA-1+) cells in peripheral blood as well as renal pathology. From our results, LPS or M-CSF combined with LPS emphasized the degree of proteinuria, glomerular deposition of immunoglobulins and mesangial proliferation, associated with accumulation of macrophages in the glomeruli. However, in immunohistological examination of kidneys from these nephritic mice, neither intercellular adhesion molecule-1 (ICAM-1), which may play an important role in the recruitment of macrophages into glomeruli, M-CSF receptor nor the number of LFA-1+ cells in peripheral blood was enhanced by M-CSF. On the other hand, M-CSF alone induced neither proteinuria nor any pathological changes and did not increase the number of glomerular Mac-1+ cells above that in saline-treated controls. These results indicate that M-CSF does not directly cause glomerulonephritis but might participate in accelerating the glomerular inflammatory process by stimulating a potent chemoattractant to recruit monocytes-macrophages into the glomeruli.
Utsunomiya
Y
Y
Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
Omura
K
K
Yokoo
T
T
Imasawa
T
T
Kawamura
T
T
Abe
A
A
Hirano
K
K
Mitarai
T
T
Maruyama
N
N
Sakai
O
O
D000818:Animals; D002455:Cell Division; D002465:Cell Movement / Q000187:drug effects*; D004195:Disease Models, Animal; D004338:Drug Combinations; D005260:Female; D005920:Glomerular Mesangium / Q000378:metabolism / Q000648:ultrastructure; D005921:Glomerulonephritis / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D007274:Injections, Intraperitoneal; D007678:Kidney Glomerulus / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D008070:Lipopolysaccharides / Q000633:toxicity; D016169:Lymphocyte Function-Associated Antigen-1 / Q000378:metabolism; D016173:Macrophage Colony-Stimulating Factor / Q000494:pharmacology*; D008264:Macrophages / Q000502:physiology*; D051379:Mice; D011507:Proteinuria / Q000209:etiology*
D004338:Drug Combinations; D008070:Lipopolysaccharides; D016169:Lymphocyte Function-Associated Antigen-1; D016173:Macrophage Colony-Stimulating Factor